Granted Patent
B2
US 12,264,332 · App. 17/516,773 · Granted Apr 1, 2025
Highly efficient gas permeable devices and methods for culturing cells
Assignee:
Wilson Wolf Manufacturing, LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention relates to methods and devices that improve cell culture efficiency. They include the use of gas permeable culture compartments that reduce the use of space while maintaining uniform culture conditions, and are more suitable for automated liquid handling. They include the integration of gas permeable materials into the traditional multiple shelf format to resolve the problem of non-uniform culture conditions. They include culture devices that use surfaces comprised of gas permeable, plasma charged silicone and can integrate traditional attachment surfaces, such as those comprised of traditional tissue culture treated polystyrene. They include culture devices that integrate gas permeable, liquid permeable membranes. A variety of benefits accrue, including more optimal culture conditions during scale up and more efficient use of inventory space, incubator space, and disposal space. Furthermore, labor and contamination risk are reduced.
Claims (3)
1. A cell growth apparatus, comprising:
an enclosure that does not include equipment for pumping gas or medium through the enclosure, the enclosure bounded by a liquid impermeable and gas permeable wall defining an interior volume capable of being filled with liquid and an exterior surface configured for contact with incubator gas, the wall forming more than one shelf with an interior surface for cells to reside upon, the interior surface of each shelf having and an opposing parallel surface located a distance away from it, each shelf being gas permeable, the shelves being located one above the other when the shelves are in a horizontal position, and the enclosure geometry having a space for incubator gas to exist below each shelf, and each shelf having an exterior surface in contact with projections that define a space for incubator gas to make contact with the exterior surface, wherein the projections are arranged in a bed of nails pattern and maintain each shelf in a horizontal position during cell culture, the enclosure is capable of being completely filled with media for optimal cell-nutrient exchange while still allowing ambient gas to make contact with a portion of the outside surface of each shelf.
2. The cell growth apparatus of claim 1 , wherein the distance from each shelf and its opposing parallel surface is equal for every shelf.
Assignments (2)
CHANGE OF NAME
Recorded Dec 4, 2024
From: WILSON WOLF MANUFACTURING CORPORATION
To: WILSON WOLF MANUFACTURING, LLC
Reel/Frame 069492/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 2, 2021
From: WILSON, JOHN R.
To: WILSON WOLF MANUFACTURING CORPORATION
Reel/Frame 057990/0136 →
Continuity (5)
Provisional Application
60873347
· Dec 7, 2006
References Cited (400)
US 3459176A
· Leonard
· 1969
[cited by applicant]
US 3839155A
· McAleer et al.
· 1974
[cited by applicant]
US 3853712A
· House et al.
· 1974
[cited by applicant]
US 3870602A
· Froman et al.
· 1975
[cited by applicant]
US 3873423A
· Munder et al.
· 1975
[cited by applicant]
US 3941661A
· Noteboom
· 1976
[cited by applicant]
US 3941662A
· Munder et al.
· 1976
[cited by applicant]
US 3948732A
· Haddad et al.
· 1976
[cited by applicant]
US 4142940A
· Modolell et al.
· 1979
[cited by applicant]
US 4228243A
· Iizuka
· 1980
[cited by applicant]
US 4296205A
· Verma
· 1981
[cited by applicant]
US 4317886A
· Johnson et al.
· 1982
[cited by applicant]
US 4435508A
· Gabridge
· 1984
[cited by applicant]
US 4640895A
· Davis
· 1987
[cited by applicant]
US 4649114A
· Miltenburger et al.
· 1987
[cited by applicant]
US 4661455A
· Hubbard
· 1987
[cited by applicant]
US 4668632A
· Young et al.
· 1987
[cited by applicant]
US 4717668A
· Keilman et al.
· 1988
[cited by applicant]
US 4734373A
· Bartal
· 1988
[cited by applicant]
US 4748124A
· Vogler
· 1988
[cited by applicant]
US 4824787A
· Serkes et al.
· 1989
[cited by applicant]
US 4829002A
· Pattillo et al.
· 1989
[cited by applicant]
US 4829004A
· Varani et al.
· 1989
[cited by applicant]
US 4839292A
· Cremonese
· 1989
[cited by applicant]
US 4847462A
· Soodak et al.
· 1989
[cited by applicant]
US 4897359A
· Oakley et al.
· 1990
[cited by applicant]
US 4906577A
· Armstrong et al.
· 1990
[cited by applicant]
US 4912058A
· Mussi et al.
· 1990
[cited by applicant]
US 4937194A
· Pattillo et al.
· 1990
[cited by applicant]
US 4937196A
· Wrasidlo et al.
· 1990
[cited by applicant]
US 4939151A
· Bacehowski et al.
· 1990
[cited by applicant]
US 4945203A
· Soodak et al.
· 1990
[cited by applicant]
US 4960706A
· Bliem et al.
· 1990
[cited by applicant]
US 5017490A
· Taiariol et al.
· 1991
[cited by applicant]
US 5026650A
· Schwarz et al.
· 1991
[cited by applicant]
US 5047347A
· Cline
· 1991
[cited by applicant]
US 5068195A
· Howell et al.
· 1991
[cited by applicant]
US 5078755A
· Tozawa et al.
· 1992
[cited by applicant]
US 5079168A
· Amiot
· 1992
[cited by applicant]
US 5139946A
· Howell et al.
· 1992
[cited by applicant]
US 5139951A
· Butz et al.
· 1992
[cited by applicant]
US 5153131A
· Wolf et al.
· 1992
[cited by applicant]
US 5173225A
· Range et al.
· 1992
[cited by applicant]
US 5225346A
· Matsumiya et al.
· 1993
[cited by applicant]
US 5240854A
· Berry et al.
· 1993
[cited by applicant]
US 5310676A
· Johansson et al.
· 1994
[cited by applicant]
US 5324428A
· Flaherty
· 1994
[cited by applicant]
US 5330908A
· Spaulding
· 1994
[cited by applicant]
US 5416022A
· Amiot
· 1995
[cited by applicant]
US 5426037A
· Pannell et al.
· 1995
[cited by applicant]
US 5437998A
· Schwarz et al.
· 1995
[cited by applicant]
US 5449617A
· Falkenberg et al.
· 1995
[cited by applicant]
US 5462874A
· Wolf et al.
· 1995
[cited by applicant]
US 5503741A
· Clark
· 1996
[cited by applicant]
US 5527705A
· Mussi et al.
· 1996
[cited by applicant]
US 5576211A
· Falkenberg et al.
· 1996
[cited by applicant]
US 5650325A
· Spielmann
· 1997
[cited by applicant]
US 5658797A
· Bader
· 1997
[cited by applicant]
US 5659997A
· Sprehe et al.
· 1997
[cited by applicant]
US 5670332A
· Kuhl et al.
· 1997
[cited by applicant]
US 5686301A
· Falkenberg et al.
· 1997
[cited by applicant]
US 5686304A
· Codner
· 1997
[cited by applicant]
US 5693537A
· Wilson et al.
· 1997
[cited by applicant]
US 5702941A
· Schwarz
· 1997
[cited by applicant]
US 5702945A
· Nagels et al.
· 1997
[cited by applicant]
US 5707869A
· Wolf et al.
· 1998
[cited by applicant]
US 5714384A
· Wilson
· 1998
[cited by applicant]
US 5736398A
· Giambernardi et al.
· 1998
[cited by applicant]
US 5759847A
· Eden et al.
· 1998
[cited by applicant]
US 5763267A
· Kurjan et al.
· 1998
[cited by applicant]
US 5763275A
· Nagels et al.
· 1998
[cited by applicant]
US 5783075A
· Eddleman et al.
· 1998
[cited by applicant]
US 5786215A
· Brown et al.
· 1998
[cited by applicant]
US 5866400A
· Palsson et al.
· 1999
[cited by applicant]
US 5866419A
· Meder
· 1999
[cited by applicant]
US 5876604A
· Nemser et al.
· 1999
[cited by applicant]
US 5902747A
· Nemser et al.
· 1999
[cited by applicant]
US 5914154A
· Nemser
· 1999
[cited by applicant]
US 5928936A
· Ingram
· 1999
[cited by applicant]
US 5935847A
· Smith et al.
· 1999
[cited by applicant]
US 5985653A
· Armstrong et al.
· 1999
[cited by applicant]
US 5989913A
· Anderson et al.
· 1999
[cited by applicant]
US 6063618A
· Weuster-Botz et al.
· 2000
[cited by applicant]
US 6130080A
· Fuller
· 2000
[cited by applicant]
US 6150159A
· Fry
· 2000
[cited by applicant]
US 6190913B1
· Singh
· 2001
[cited by applicant]
US 6228607B1
· Kersten et al.
· 2001
[cited by applicant]
US 6297046B1
· Smith et al.
· 2001
[cited by applicant]
US 6306491B1
· Kram et al.
· 2001
[cited by applicant]
US 6455310B1
· Barbera-Guillem
· 2002
[cited by applicant]
US 6468792B1
· Bader
· 2002
[cited by applicant]
US 6479252B1
· Barbera-Guillem et al.
· 2002
[cited by applicant]
US 6562616B1
· Toner et al.
· 2003
[cited by applicant]
US 6569675B2
· Wall et al.
· 2003
[cited by applicant]
US 6605463B1
· Bader
· 2003
[cited by applicant]
US 6759245B1
· Toner et al.
· 2004
[cited by applicant]
US 6821772B2
· Barbera-Guillem et al.
· 2004
[cited by applicant]
US 6855542B2
· DiMilla et al.
· 2005
[cited by applicant]
US 6900055B1
· Fuller et al.
· 2005
[cited by applicant]
US 7229820B2
· Wilson
· 2007
[cited by applicant]
US 7560274B1
· Fuller et al.
· 2009
[cited by applicant]
US 7745209B2
· Martin et al.
· 2010
[cited by applicant]
US 8158426B2
· Wilson
· 2012
[cited by applicant]
US 8158427B2
· Wilson
· 2012
[cited by applicant]
US 8168432B2
· Wilson
· 2012
[cited by applicant]
US 8518692B2
· Wilson
· 2013
[cited by applicant]
US 8697443B2
· Wilson et al.
· 2014
[cited by applicant]
US 8809044B2
· Wilson
· 2014
[cited by applicant]
US 9441192B2
· Wilson et al.
· 2016
[cited by applicant]
US 9732317B2
· Wilson
· 2017
[cited by applicant]
US 20020110905A1
· Barbera-Guillem et al.
· 2002
[cited by applicant]
US 20020119121A1
· Vitiello et al.
· 2002
[cited by applicant]
US 20020197710A1
· Yoo et al.
· 2002
[cited by applicant]
US 20030008388A1
· Barbera-Guillem et al.
· 2003
[cited by applicant]
US 20030017142A1
· Toner et al.
· 2003
[cited by applicant]
US 20030077816A1
· Kronenthal et al.
· 2003
[cited by applicant]
US 20040029266A1
· Barbera-Guillem
· 2004
[cited by applicant]
US 20040067585A1
· Wang et al.
· 2004
[cited by applicant]
US 20040072347A1
· Schuler
· 2004
[cited by applicant]
US 20040110199A1
· Montemagno et al.
· 2004
[cited by applicant]
US 20050032205A1
· Smith et al.
· 2005
[cited by applicant]
US 20180355300A1
· Martin
· 2018
[cited by applicant]
CA 2105419
· 1994
[cited by applicant]
CN 1441841A
· 2003
[cited by applicant]
DE 4229334
· 1994
[cited by applicant]
EP 0155237A2
· 1985
[cited by applicant]
EP 264464
· 1988
[cited by applicant]
EP 0280054A1
· 1988
[cited by applicant]
EP 0647707
· 1995
[cited by applicant]
EP 0700990
· 1996
[cited by applicant]
EP 0725134A2
· 1996
[cited by applicant]
EP 0866122A2
· 1998
[cited by applicant]
EP 353893
· 1999
[cited by applicant]
EP 0890636
· 2001
[cited by applicant]
EP 1245670
· 2002
[cited by applicant]
FR 2666094
· 1992
[cited by applicant]
GB 2268187
· 1994
[cited by applicant]
JP 59220182
· 1984
[cited by applicant]
JP 6434283
· 1987
[cited by applicant]
JP 5123182
· 1993
[cited by applicant]
JP 78267
· 1995
[cited by applicant]
JP 734699
· 1995
[cited by applicant]
JP 11028083A
· 1999
[cited by applicant]
JP 2002528567A
· 2002
[cited by applicant]
JP 2002335946
· 2002
[cited by applicant]
JP 2003503022
· 2003
[cited by applicant]
JP 2004129568A
· 2004
[cited by applicant]
WO 9013628A1
· 1990
[cited by applicant]
WO 1996030497
· 1996
[cited by applicant]
WO 1998017362
· 1998
[cited by applicant]
WO 9831782A1
· 1998
[cited by applicant]
WO 1998053894
· 1998
[cited by applicant]
WO 0056870
· 2000
[cited by applicant]
WO 2000058437
· 2000
[cited by applicant]
WO 2000078920
· 2000
[cited by applicant]
WO 2000078932
· 2000
[cited by applicant]
WO 0192462
· 2001
[cited by applicant]
WO 0242419A2
· 2002
[cited by applicant]
WO 0242419A3
· 2002
[cited by applicant]
WO 0244341A2
· 2002
[cited by applicant]
WO 200264730
· 2002
[cited by applicant]
WO 2003060061
· 2003
[cited by applicant]
WO 2005035728
· 2005
[cited by applicant]
US 6,465,252 B1, 10/2002, Toner et al. (withdrawn)
[cited by applicant]
Reexamination No. 90/014,538, Exhibit 2019 Office Action of Apr. 18, 2011 in U.S. Appl. No. 11/952,848 File History, filed Apr. 19, 2021, 10.
[cited by applicant]
Reexamination No. 90/014,538, Exhibit 2020 Order of Oct. 6, 2020 in 0:20-cv-00700DWF-TNL, filed Apr. 19, 2021, 43.
[cited by applicant]
Reexamination No. 90/014,538, Interview Summary filed Jul. 28, 2021, 10.
[cited by applicant]
Reexamination No. 90/014,540, Transmittal of Exhibit 2016 Second Declaration of Dr. Maury Cosman and Exhibit 2017 Third Declaration of Dr. Maury D. Cosman, filed Jul. 13, 2021, 58.
[cited by applicant]
Reexamination No. 90/014,540 Request for Extension of Time Granted mailed Jun. 7, 2021, 3.
[cited by applicant]
Reexamination No. 90/014,541 Advisory Action mailed Nov. 4, 2021, 4.
[cited by applicant]
Reexamination No. 90/014,541 Applicant Summary of Interview with Examiner filed Jun. 21, 2021, 5.
[cited by applicant]
Reexamination No. 90/014,541 Authorization for Internet Communications filed May 7, 2021, 4.
[cited by applicant]
Reexamination No. 90/014,541 Communication Regarding Power of Attorney mailed Apr. 27, 2021, 2.
[cited by applicant]
Reexamination No. 90/014,541 Decision on Petition for Extension of Time in Reexamination mailed Sep. 13, 2021, 5.
[cited by applicant]
Reexamination No. 90/014,541 Decision on Petition for Extension of Time in Reexamination mailed Sep. 2, 2021, 6.
[cited by applicant]
Reexamination No. 90/014,541 Examiner Interview Summary mailed Jun. 3, 2021, 14.
[cited by applicant]
Reexamination No. 90/014,541 Exhibit 2021 Declaration of Dr. Maury D. Cosman filed Jun. 1, 2021, 37.
[cited by applicant]
Reexamination No. 90/014,541, filed Jun. 1, 2021 Exhibit 2022 Restriction Requirement of Jun. 8, 2006 in U.S. Appl. No. 10/961,814, filed Jun. 1, 2021, 6.
[cited by applicant]
Reexamination No. 90/014,541 Final Rejection mailed Jul. 19, 2021, 35.
[cited by applicant]
Reexamination No. 90/014,541 Information Disclosure Statement filed Jun. 22, 2021, 15.
[cited by applicant]
Reexamination No. 90/014,541 Information Disclosure Statement filed Jun. 28, 2021, 8.
[cited by applicant]
Reexamination No. 90/014,541 Information Disclosure Statement filed Sep. 1, 2021, 6.
[cited by applicant]
Reexamination No. 90/014,541 Non-Final Office Action mailed Apr. 1, 2021, 34.
[cited by applicant]
Reexamination No. 90/014,541 Notice of Appeal filed Dec. 17, 2021, 8.
[cited by applicant]
Reexamination No. 90/014,541 Patent Owner's Response to Final Office Action filed Oct. 19, 2021, 47.
[cited by applicant]
Reexamination No. 90/014,541 Patent Owner's Response to Office Action filed Jun. 1, 2021, 106.
[cited by applicant]
Reexamination No. 90/014,541 Patent Owner's Supplemental Response to Final Office Action filed Oct. 27, 2021, 6.
[cited by applicant]
Reexamination No. 90/014,541 Petition for Extension of Time filed Aug. 25, 2021, 8.
[cited by applicant]
Reexamination No. 90/014,541 Petition for Extension of Time filed Sep. 2, 2021, 9.
[cited by applicant]
Reexamination No. 90/014,541 Power of Attorney filed Apr. 22, 2021, 7.
[cited by applicant]
Reexamination No. 90/014,540 EXH, “Large-Scale Ex Vivo Expansion and Characterization of Natural Killer Cells for Clinical Applications”, Cytotherapy, 2012:14-1131-1143, filed Jul. 12, 2021, 14.
[cited by applicant]
Reexamination No. 90/014,540 EXH, “Optimizing the production of suspension cells using the G-Rex “M” Series”, Molecular Therapy-Methods & Clinical Development (2014) 1, 14015; doi: 10.1038/mtm2014.15, published Online M…
[cited by applicant]
U.S. Appl. No. 12/753,573, filed Apr. 2, 2010, Wilson et al., Utility application.
[cited by applicant]
U.S. Appl. No. 14/810,071, filed Jul. 27, 2015, Wilson et al., Utility application.
[cited by applicant]
U.S. Appl. No. 60,509,651, filed Oct. 8, 2003, Wilson et al.
[cited by applicant]
U.S. Appl. No. 60/873,347, filed Dec. 7, 2006, Wilson et al.
[cited by applicant]
Barbera-Guillem, E., “Overcoming Cell Culture Barriers to Meet the Demands of Cell Biology and Biotechnology,” Am. Biotech. Lab., May 2001 (3 pages).
[cited by applicant]
CLINIcell 250® commercial product and User Instructions V-2 listed as Exhibit 4 in Corning Incorporated's Prior Art Statement in Civil No. 13-210(DWF/AJB) D. Minn. dated Sep. 5, 2013 (5 pages).
[cited by applicant]
Corning CellCUBE® Systems URL:<https://ecatalog.corning.com/life-sciences/b2c/US/en/Bioprocess-and-Scale-up/CellCube%C2%AE/CellCube-System/Corning%C2%AE-CellCube%C2%AE-Systems/p/corningCellCubeSystems> Accessed on the I…
[cited by applicant]
Corning CellSTACK® Culture Chambers URL :<https://ecatalog.corning.com/life-sciences/b2c/US/en/Browse-Products-by-Application/Cell-Therapy-and-Vaccines/CellSTACK%C2%AE/Corning%C2%AE-CellSTACK%C2%AE-Culture-Chambers/p/co…
[cited by applicant]
Corning E-CUBE™ Culture System Kit URL :<https://ecatalog.corning.com/life-sciences/b2c/US/en/Bioprocess-and-Scale-up/CellCube%C2%AE/E-Cube-System/E-Cube%E2%84%A2-Culture-System-Kit-%28without-CellCube%C2%AE-Module%29/p…
[cited by applicant]
Corning Hyperflask Cell Culture Vessel Instructions for Use ©2008 (4 pages).
[cited by applicant]
Corning Hyperflask Cell Culture Vessels dated Jul. 1, 2013 (2 pages).
[cited by applicant]
Corning Hyperstack Cell Culture Vessel Closed System Protocol Guide ©2011 (4 pages).
[cited by applicant]
Corning Hyperstack Cell Culture Vessel dated Jul. 1, 2013 (1 page).
[cited by applicant]
Pardo, Ana Maria P. et al. “A Comparative Study Examining Corning's Hyperstack Cell Culture Vessel Technology”, submitted with Plaintiffs' Claim Charts in Civil No. 13-210(DWF/AJB) (D. Minn.) dated Jul. 1, 2013 (1 page).
[cited by applicant]
Pardo, Ana Maria P. et al. “Corning Hyperstack Cell Culture Vessel: Performance Analysis”, ©2011 (8 pages).
[cited by applicant]
Pardo, Ana Maria P. et al. “Expansion of Human Mesenchymal Stem Cells Using Coming Hyper Technology Cell Culture Vessels”, ©2012 (6 page).
[cited by applicant]
Pardo, Pilar et al. “Bioprocess Scale-Up Using Coming Hyperstack Vessels”, Bioprocess International Industry Yearbook 2011-2012 pp. 22-23.
[cited by applicant]
Petaka™ Cell Culturing System URL: <https://www.neuromics.com/petaka-cell-culturing-system> Accessed on the Internet Mar. 1, 2021 (3 pages).
[cited by applicant]
Ryan, John A. “Growing More Cells: A Simple Guide to Small Volume Cell Culture Scale-Up” ©2010, 2012 (16 pages).
[cited by applicant]
Stang, B.V. “Monoclonal Antibody Production in Gas-Permeable Flexible Flasks, Using Serum-Free Media,” Contemporary Topics, 37(6) 55-60 (1999).
[cited by applicant]
Titus, Kim et al. “Closed System Cell Culture Protocol Using HYPERStack Vessels with Gas Permeable Material Technology”, Journal of Visualized Experiments, Nov. 29, 2010 (5 pages).
[cited by applicant]
Veliz, R.V. “Alternative Techniques to Obtain Monoclonal Antibodies at a Small Scale: Current State and Future Goals,” Biotecnologia Aplicada, 19, 119-131 (2002).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Non-Final Office Action dated Feb. 19, 2021 (21 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 1037
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 1038
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 1039
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 1033 Reply Declaration of Charles L. Crespi, Ph.D. Pursuant to 37 C.F.R. § 1.132 (27 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Reply of Third-Party Requester Corning Incorporated to Patent Owner's Statement under 35 U.S.C. § 304, filed Dec. 2, 2020 (71 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2001 Declaration of Dr. Maury D. Cosman (23 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2002 Declaration of Dr. Emilio Barbera-Guillem (29 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2006 Response of Jul. 6, 2020 in U.S. Appl. No. 15/671,485 (7 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2009 Declaration of John Wilson dated Oct. 2, 2020 (36 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2010 Wilson Spreadsheet Showing Diligence (24 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2013 Corning Guide for Identifying and Correcting Common Cell Growth Patterns (13 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2014 Closed System Cell Culture Protocol Using HYPERStack Vessel with Gas Permeable Material Technology (6 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538, Exhibit 2015 Biographical Sketch of John Wilson (6 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Patent Owner's Statement Under 35 U.S.C. 304, filed Oct. 2, 2020 (64 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Order Granting Request for Ex Parte Reexamination mailed Aug. 4, 2020 (21 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Examiner Interview Summary mailed Jul. 16, 2020 (3 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Litigation Search Report dated Jul. 7, 2020 (40 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Notice of Assignment of Reexamination Request mailed Jun. 30, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Notice of Reexamination Request Filing Date mailed Jun. 30, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Patent Assignment Abstract of Title dated Jun. 26, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Third Party Requester Power of Attorney dated Apr. 29, 2020 (5 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Request for Ex Parte Reexamation dated Jun. 26, 2020 (107 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1001 Declaration of Charles L. Crespi, Ph.D. Pursuant ot 37 C.F.R. § 1.132 (184 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1002 Curriculum Vitae of Charles L. Crespi (11 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1007 Complaint filed in
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1008 Complaint filed in
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1013 Office Action in U.S. Appl. No. 14/321,933, dated Nov. 30, 2015 (14 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1014 Office Action in U.S. Appl. No. 14/321,933, dated Jun. 8, 2016 (19 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1015 Amendment in U.S. Appl. No. 14/321,933, dated Dec. 8, 2016 (12 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1024 Declaration of John R. Wilson Pursuant to 37 C.F.R. 1.131 in U.S. Appl. No. 14/321,933, dated Dec. 8, 2016 (14 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1025 Computer-based Comparison of U.S. Patent Application Publication No. 2007/0026516 A1 to Martin et al. to U.S. Appl. No. 60/702,896 to Martin et al. (19 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1028 Notice of Allowance in U.S. Appl. No. 14/321,933, mailed Apr. 7, 2017 (9 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Exhibit 1032 Declaration of Carla M. Ford Pursuant to 37 C.F.R. § 1.132 (5 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,538 Information Disclosure Statement filed by Third Party Requester, Jun. 26, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Reply of Third-Party Requester Corning Incorporated to Patent Owner's Statement under 35 U.S.C. § 304, filed Nov. 30, 2020 (56 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1030 Reply Declaration of Charles L. Crespi, Ph.D. Pursuant to 37 C.F.R. § 1.132 (21 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1034 Bognar et al., “Large Scale Propagation of BHK21 Cells Using the Opticell Culture System,” J. Tissue Culture Methods 8(4): 147-154 (1983) (9 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Patent Owner's Statement Under 35 U.S.C. 304 filed Sep. 30, 2020 (48 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Examiner Interview Summary mailed Aug. 21, 2020 (2 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Order Granting Request for Ex Parte Reexamination mailed Jul. 31, 2020 (23 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Litigation Search Report dated Jul. 9, 2020 (8 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Notice of Reexamination Request Filing Date mailed Jul. 6, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Notice of Assignment of Reexamination Request mailed Jul. 6, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Patent Assignment Abstract of Title dated Jul. 6, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Third Party Requester Power of Attorney dated Apr. 29, 2020 (5 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1008 First Amended Complaint filed in
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1023 Application as filed in U.S. Appl. No. 14/810,071, filed Jul. 27, 2015 (124 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1024 Preliminary Amendment in U.S. Appl. No. 14/810,071, filed Dec. 15, 2015 (12 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Office Action in U.S. Appl. No. 14/810,071, mailed Dec. 16, 2015 (12 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1027 Amendment in U.S. Appl. No. 14/810,071, filed Jan. 25, 2016 (13 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1028 Notice of Allowance and Notice of Allowability in U.S. Appl. No. 14/810,071, mailed May 5, 2016 (9 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1029 Declaration of Carla M. Ford Pursuant ot 37 C.F.R. § 1.132 (5 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Request for Ex Parte Reexamination dated Jun. 26, 2020 (109 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Information Disclosure Statement by Third Party Requester filed Jun. 26, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Request for Ex Parte Reexamination Transmittal dated Jun. 26, 2020 (4 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,540 Exhibit 1002 Declaration of Charles L. Crespi, Ph.D. Pursuant to 37 C.F.R. § 1.132 (153 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Reply of Third-Party Requester Corning Incorporated to Patent Owner's Statement under 35 U.S.C. § 304, filed Nov. 30, 2020 (62 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Exhibit 1030 Reply Declaration of Charles L. Crepsi, Ph.D. Pursuant to 37 C.F.R. § 1.132 (21 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Order Granting Request for Ex Parte Reexamination mailed Jul. 31, 2020 (13 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Examiner Interview Summary mailed Jul. 30, 2020 (3 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Notice of Assignment of Reexamination Request mailed Jul. 30, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Notice of Reexamination Request Filing Date mailed Jul. 30, 2020 (1 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Patent Assignment Abstract of Title dated Jun. 30, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Litigation Search Report dated Jun. 29, 2020 (76 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Third Party Requester Power of Attorney dated Apr. 29, 2020 (5 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Request for Ex Parte Reexamination dated Jun. 26, 2020 (123 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Information Disclosure Statement filed by Third Party Requester filed Jun. 26, 2020 (1 page).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Exhibit 1002 Declaration of Charles L. Crepsi, Ph.D. Pursuant ot 37 C.F.R. § 1.132 (173 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Exhibit 1024 Office Action in U.S. Appl. No. 12/753,573, mailed Jun. 18, 2013 (12 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Exhibit 1025 Amendment in U.S. Appl. No. 12/753,573, filed Sep. 20, 2013 (20 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Exhibit 1026 Application as filed in U.S. Appl. No. 12/753,573, filed Apr. 2, 2010 (113 pages).
[cited by applicant]
U.S. Ex Parte Reexamination No. 90/014,541 Exhibit 1027 Declaration of Carla M. Ford Pursuant to 37 C.F.R. § 1.132 (5 pages).
[cited by applicant]
Decision of U.S. Court of Appeals for the Federal Circuit in Appeal 2018-1980, entered Oct. 21, 2019 (21 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1001 Transcript of Telephone Conference before APJ Sally Gardner Lane on Dec. 14, 2016 (19 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1003 First Declaration of Charles L. Crepsi, Ph.D. (49 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1004 Curriculum vitae of Charles L. Crespi, Ph.D. (10 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1006 Detailed drawings (Figs. A-D) depicting the HYPERFlask™ cell culture vessel identical to the one on display and demonstrated at the SBS 12th Annual Conference & Exhibition in Seatt…
[cited by applicant]
U.S. Interference 106,060 Exhibit 1010 Webster's Third New International Dictionary of the English Language, Unabridged, Merriam-Webster Inc., Springfield, MA (2002), pp. 66, 552, 1133, 1146, 1173-74, 1375-76, 1655, 168…
[cited by applicant]
U.S. Interference 106,060 Exhibit 1011 Second Declaration of Charles L. Crespi, Ph.D. (172 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1013 Freshney, R.I., Culture of Animal Cells: A Manual of Basic Technique, 4th ed. (Wiley-Blackwell 2000), pp. 24-27, 31-34, 89-104, 182.
[cited by applicant]
U.S. Interference 106,060 Exhibit 1014 Notice of Allowance in U.S. Appl. No. 11/952,848, mailed Jun. 11, 2014 (8 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1015 Interview Summary in U.S. Appl. No. 11/952,848, dated May 27, 2014 (3 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1016 Amendment in U.S. Appl. No. 11/952,848, filed Apr. 30, 2012 (12 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1017 First Declaration of Todd M. Upton, Ph.D. (182 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1018 Curriculum vitae of Todd M. Upton, Ph.D. (8 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1019 Upton et al. “A Novel Flask Design for High Density Cell Culture” poster as presented at the SBS 12th Annual Conference & Exhibition in Seattle, Washington, Sep. 17-21, 2006 (1 pag…
[cited by applicant]
U.S. Interference 106,060 Exhibit 1020 Certificate of Merit from the Society for Biomolecular Sciences at the SBS Conference in recognition for the best presenation in the Cell and Protein Production Poster Session enti…
[cited by applicant]
U.S. Interference 106,060 Exhibit 1021 Society Updates, Awards, Poster Awards, J. Biomolecular Screening 11(8): 887-901, 894-895 (Dec. 1, 2006) (15 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1022 SLAS Discovery, Table of Contents 11(8), Articles, Society Updates (Dec. 1, 2006), http://journals.sagepub.com/toc/jbxb/11/8 (last visited Janaury 24, 2017) (9 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1023 First Declaration of Jeanne (Phillips) Anthony (15 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1024 First Declaration of Kimberly Titus (8 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1025 Brochure mailed to conference attendees in advance of the SBS 12th Annual Conference & Exhibition in Seattle, Washington, Sep. 17-21, 2006 (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1026 Color photograph of a copy of the HYPERFlask™ cell culture vessel identical to the one on display and demonstrated at the SBS 12th Annual Conference & Exhibition in Seattle, Washin…
[cited by applicant]
U.S. Interference 106,060 Exhibit 1027 Color copies of the back wall posters on display at the Corning Booth at the SBS 12th Annual Conference & Exhibition in Seattle, Washington, Sep. 17-21, 2006 (7 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1028 2006 Prospectus for the SBS 12th Annual Conference & Exhibition in Seattle, Washington, Sep. 17-21, 2006 (16 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1029 Copies of the stand-alone poster boards on display at the Corning Booth at the SBS 12th Annual Conference & Exhibition in Seattle, Washington, Sep. 17-21, 2006 (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1030 Conception document for priority statement (10 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1031 Excel worksheet “Sheet1” in Excel spreadsheet entitled “Central Region HYPERFlask Leads” and accompanying screen shot of the Microsoft Excel File Information (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1032 Excel worksheet “Sheet1” in Excel spreadsheet entitled “East Region HYPERFlask Leads” and accompanying screen shot of the Microsoft Excel File Information (3 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1033 Excel worksheet “Sheet1” in Excel spreadsheet entitled “NE Region HYPERFlask Leads” and accompanying screen shot of the Microsoft Excel File Information (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1034 Excel worksheet “Sheet1” in Excel spreadsheet entitled “SE Region HYPERFlask Leads” and accompanying screen shot of the Microsoft Excel File Information (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1035 Excel worksheet “Sheet1” in Excel spreadsheet entitled “West Region HYPERFlask Leads” and accompanying screen shot of the Microsoft Excel File Information (3 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1036 Excel worksheet “Sheet1” in Excel spreadsheet entitled “Canada Region HYPERFlask Leads” and accompanying screen shot of the Microsoft Excel File Information (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1037 First Declaration of Carla M. Ford (7 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1038 Figure 1 excerpted from Upton et al. “A Novel Flask Design for High Density Cell Culture”, poster as presented at the SBS 12th Annual Conference & Exhibition in Seattle, Washington…
[cited by applicant]
U.S. Interference 106,060 Exhibit 1039 Applicant Initiated Interview Request Form in U.S. Appl. No. 11/952,848, dated Apr. 16, 2012 (8 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1040 Excel worksheet entitled “Alphabetically” in Excel spreadsheet entitled “SBS 2006 Leads” and accompanying screen shot of the Microsof Excel File Information (9 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1041 Excel worksheet entitled “Sheet 1” in Excel spreadsheet entitled “SBS Poster Leads” and accompanying screen shot of the Microsof Excel File Information (3 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1042 Redline comparison of the Declaration of John R. Wilson (WX 2004) to the Declaration of Matthew S. Croughan, Ph.D. (WX 2002) (59 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1043 Enlarged Figure 6 (from MX 1002) (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1048 Response to Notice and Statement of Opposition in European Patent No. 2336293 dated Apr. 24, 2017 (26 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1049 Statement of Opposition dated Nov. 10, 2026 in European Patent No. 2336293 (41 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1050 Filing Receipt in U.S. Appl. No. 14/321,933 dated Jul. 17, 2014 (3 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1051 Amendment and Response to Non-Final Office Action in U.S. Appl. No. 14/321,933 mailed May 26, 2016 (9 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1052 Second Declaration of Kimberly Titus (4 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1053 Second Declaration of Carla M. Ford (5 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1054 Transcript of the Deposition of Matthew S. Croughan, Ph.D. taked May 23, 2017 (103 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1055 Transcript of the Deposition of John R. Wilson taken May 31, 2017 (92 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1056 Transcript of the Deposition of Timothy Holland taken Jun. 1, 2017 (64 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1057 Martin Objections to Wilson Exhibits dated May 12, 2017 (7 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 1058
[cited by applicant]
U.S. Interference 106,060 Exhibit 1059
[cited by applicant]
U.S. Interference 106,060 Exhibit 2001 SBIR Grant Application, submitted by Wilson Wolf Manufacturing Corporation, received Feb. 19, 2004 (partially redacted) (41 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2002 Declaration of Matthew S. Croughan, Ph.D. (43 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2003 Curriculum Vitae of Matthew S. Croughan, Ph.D. (7 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2004 Declaration of John R. Wilson (58 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2005 Biographical Sketch of John R. Wilson (4 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2006 Jianjian Jin et al., Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-Permeable Flasks to Nos. Needed for Patient Treatment, 35 J. Immunotherapy 283 (…
[cited by applicant]
U.S. Interference 106,060 Exhibit 2007 Declaration of Tim S. Holland (28 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2008 Transcript of Cross Examination of Jeanne Anthony on Apr. 11, 2017 (88 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2009 Transcript of Cross Examination of Kimberly Titus on Apr. 11, 2017 (50 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2010 Transcript of Cross Examination of Todd M. Upton, Ph.D. on Apr. 12, 2017 (96 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2011 Transcript of Cross Examination of Charles L. Crespi, Ph.D. on Apr. 13, 2017 (100 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2012 Fig. B of Exhibit 1006, colored by Todd M. Upton, Ph.D. (1 page).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2013 Fig B of Exhibit 1006, colored by Kimberly Titus (1 page).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2014 Annotated Fig. B of Exhibit 1006 (1 page).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2015 Annotated Fig. C of Exhibit 1006 (1 page).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2016 Non-Final Office Action in U.S. Appl. No. 11/433,859, mailed Jun. 15, 2009 (10 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2017 Amendment and Response in U.S. Appl. No. 11/433,859 dated Oct. 14, 2009 (14 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2018 Final Office Action in U.S. Appl. No. 11/433,859 mailed Jan. 15, 2010 (6 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2019 Amendment and Response in U.S. Appl. No. 11/433,859 dated Mar. 15, 2010 (18 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2020 U.S. Appl. No. 11/433,859 as filed on May 11, 2008 (33 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2021 Declaration of Nathan J. Witzany (4 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2022
[cited by applicant]
U.S. Interference 106,060 Exhibit 2023
[cited by applicant]
U.S. Interference 106,060 Exhibit 2024
[cited by applicant]
U.S. Interference 106,060 Exhibit 2025 Ex Parte Brocade Commc'ns Sys., Inc., 2013 WL 6700331 (Pat. Tr. & App. Bd. Dec. 19, 2013) (21 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2026 Ex Parte Williams, 2002 WL 851848 (Bd. Pat. App. & Int.) (5 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2027
[cited by applicant]
U.S. Interference 106,060 Exhibit 2028
[cited by applicant]
U.S. Interference 106,060 Exhibit 2029 Declaration of Sri K. Sankaran (3 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2030 Correspondence with counsel for Senior Party Martin (2 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2031 Wilson Objections to Admissibility of Evidence (for exhibits submitted with Martin Motions 1, 2, and 3), served to Senior Party Martin on Feb. 23, 2017 (9 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2032 Wilson Objections to Admissibility of Evidence (for exhibits submitted with Martin Motions 1, 2, and 3), served to Senior Party Martin on Jun. 21, 2017 (4 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2033
[cited by applicant]
U.S. Interference 106,060 Exhibit 2034
[cited by applicant]
U.S. Interference 106,060 Exhibit 2035
[cited by applicant]
U.S. Interference 106,060 Exhibit 2036
[cited by applicant]
U.S. Interference 106,060 Exhibit 2037
[cited by applicant]
U.S. Interference 106,060 Exhibit 2038 Complaint of Nautilus Motor Tanker Co., Ltd., 862 F. Suppp. 1251 (D.N.J. 1994) (8 pages).
[cited by applicant]
U.S. Interference 106,060 Exhibit 2039
[cited by applicant]
U.S. Interference 106,060 Exhibit 2040
[cited by applicant]
U.S. Interference 106,060 Exhibit 2041
[cited by applicant]
U.S. Interference 106,060 Exhibit 2042
[cited by applicant]
U.S. Interference 106,060 Exhibit 2043
[cited by applicant]
U.S. Interference 106,060 Document No. 1 Notice to Declare an Interference dated Oct. 31, 2016 (7 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 2 Standing Order Entered Mar. 8, 2011 (81 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 3 Wilson Notice of Real Party-in-Interest dated Nov. 14, 2016 (3 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 4 Wilson Notice of Related Proceedings dated Nov. 14, 2016 (3 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 5 Wilson Notice of Lead and Backup Lead Counsel dated Nov. 14, 2016 (4 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 6 Wilson Clean Copy of Claims dated Nov. 14, 2016 (15 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 7 Martin Notice of Real Party-in-Interest dated Nov. 14, 2016 (3 pages).
[cited by applicant]
U.S. Interference 106,060 Document No. 8 Martin Notice of Related Proceedings dated Nov. 14, 2016 (3 pages).
[cited by applicant]